Clinical Trials Browser

Completed × Head and Neck Neoplasms × Imatinib Mesylate × Clear all

NCT00045669 2019-02-15

Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

Phase 2 Completed

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00485485 2012-08-07

Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer

Phase 2 Completed

7 enrolled 7 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell